Goodman Advisory Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8
| Closed | -$57 | – | 181 |
|
|
2025
Q1 | $57 | Buy |
+8
| New | +$57 | ﹤0.01% | 180 |
|
|
2024
Q4 | – | Sell |
-8
| Closed | -$164 | – | 135 |
|
|
2024
Q3 | $164 | Hold |
8
| – | – | ﹤0.01% | 194 |
|
|
2024
Q2 | $179 | Hold |
8
| – | – | ﹤0.01% | 175 |
|
|
2024
Q1 | $220 | Hold |
8
| – | – | ﹤0.01% | 169 |
|
|
2023
Q4 | $244 | Hold |
8
| – | – | ﹤0.01% | 150 |
|
|
2023
Q3 | $253 | Hold |
8
| – | – | ﹤0.01% | 155 |
|
|
2023
Q2 | $326 | Hold |
8
| – | – | ﹤0.01% | 154 |
|
|
2023
Q1 | $298 | Hold |
8
| – | – | ﹤0.01% | 156 |
|
|
2022
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 157 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 167 |
|
|
2022
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 178 |
|